We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
SELLAS Life Sciences Group Inc | NASDAQ:SLS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -0.73% | 1.36 | 1.36 | 1.39 | 1.39 | 1.32 | 1.38 | 860,451 | 23:18:29 |
FORM 3
|
Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person * Hudson Bay Capital Management LP |
2. Date of Event Requiring Statement (MM/DD/YYYY)
|
3. Issuer Name and Ticker or Trading Symbol Galena Biopharma, Inc. [GALE] |
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
___
X
___ 10% Owner
_____ Officer (give title below) _____ Other (specify below) |
|
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned |
|||
1.Title of Security
(Instr. 4) |
2. Amount of Securities Beneficially Owned
(Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) |
4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
Common Stock, par value $0.001 per share ("Common Stock") | 4400000 | I | See footnote (1) |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||
1. Title of Derivate Security
(Instr. 4) |
2. Date Exercisable and Expiration Date
(MM/DD/YYYY) |
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) |
6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Warrant (right to buy) | 3/18/2015 | 3/18/2020 | Common Stock | 62500 | $41.6 | I | See footnote (1) |
Warrant (right to buy) | 1/7/2016 | 1/21/2021 | Common Stock | 54545 | $28.4 | I | See footnote (1) |
Warrant (right to buy) | 4/21/2012 | 4/20/2017 | Common Stock | 1 | $1.0 | I | See footnote (1) |
Warrant (right to buy) | 2/8/2017 | 2/8/2022 | Common Stock | 4400000 | $1.1 | I | See footnote (1) |
Call Options (obligation to sell) | (2) | 1/19/2018 | Common Stock | 5000 | $1.0 | I | See footnote (1) |
Call Options (obligation to sell) | (2) | 1/19/2018 | Common Stock | 15300 | $1.5 | I | See footnote (1) |
Call Options (obligation to sell) | (2) | 1/19/2018 | Common Stock | 30075 | $2.0 | I | See footnote (1) |
Call Options (obligation to sell) | (2) | 1/19/2018 | Common Stock | 3400 | $3.0 | I | See footnote (1) |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Hudson Bay Capital Management LP
777 THIRD AVE., 30TH FLOOR NEW YORK, NY 10017 |
|
X |
|
|
|
Gerber Sander
C/O HUDSON BAY CAPITAL MANAGEMENT, L.P. 777 THIRD AVENUE, 30TH FLOOR NEW YORK, NY 10017 |
|
X |
|
|
Signatures
|
||
Hudson Bay Capital Management LP, By: /s/ Sander Gerber, Authorized Signatory | 2/10/2017 | |
** Signature of Reporting Person | Date | |
/s/ Sander Gerber | 2/10/2017 | |
** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year SELLAS Life Sciences Chart |
1 Month SELLAS Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions